HeartCore Sells 51% Sigmaways Stake, Eliminates $3.6M Deficit to Boost IPO Focus
HTCR•HeartCore sold its 51% stake in Sigmaways and assigned related intercompany loans to a third party, removing a subsidiary with a $3.6 million shareholders’ deficit. The move is expected to strengthen HeartCore’s consolidated financial profile and free resources for its three Go IPO and two M&A advisory engagements.
1. Completion of Sigmaways Divestiture
HeartCore completed the sale of its 51% stake in Sigmaways and assigned related intercompany loans to a third party, removing a loss-making unit acquired in 2023.
2. Strategic Rationale
Sigmaways had incurred continued revenue declines, operating losses and held a $3.6 million shareholders’ deficit as of March 31, 2026, which weighed on HeartCore’s consolidated results.
3. Financial Impact
By divesting the non-core subsidiary, HeartCore expects to strengthen its consolidated financial profile, reduce future exposure to Sigmaways’ losses and improve working capital needs.
4. Future Growth Focus
The company will redirect management attention and resources to its three Go IPO client engagements and two M&A advisory projects, while evaluating expansion into financial services and capital markets advisory.
